Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

6.82USD
22 May 2015
Change (% chg)

$0.11 (+1.64%)
Prev Close
$6.71
Open
$6.67
Day's High
$7.06
Day's Low
$6.65
Volume
41,608
Avg. Vol
60,346
52-wk High
$11.40
52-wk Low
$3.73

ORMP.OQ

Chart for ORMP.OQ

About

Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed’s flagship product, an orally ingestible insulin capsule in phase II clinical trials, is focused on the treatment of diabetes. The Company is developing orally ingestible... (more)

Overall

Beta: -0.21
Market Cap(Mil.): $73.82
Shares Outstanding(Mil.): 10.82
Dividend: --
Yield (%): --

Financials

  ORMP.OQ Industry Sector
P/E (TTM): -- 309.95 39.17
EPS (TTM): -0.69 -- --
ROI: -30.57 -5.54 15.58
ROE: -30.61 -6.56 16.57
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$1,000.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks